김태환 교수 연구실
article|
bronze
·인용수 129
·2022
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Atul Deodhar, Filip Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée van der Heijde, Tae‐Hwan Kim, Mitsumasa Kishimoto, Ricardo Blanco, Yuanyuan Duan, Yihan Li, Aileen L. Pangan, Peter Wung, In‐Ho Song
IF 88.5The Lancet
키워드
MedicinePlaceboAnkylosing spondylitisClinical endpointInternal medicineAxial spondyloarthritisRandomized controlled trialC-reactive proteinClinical trialPhysical therapy